drugset / Trial / NCT01452906

A Drug-Drug Interaction Study of Omeprazole and PA21

NCT01452906

Phase 1 Completed 45 enrolled Vifor Pharma
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine if Omeprazole is affected by PA21.

Timeline

Start
2011-09
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 40 mg
Subject PA21 Unknown 15 g

Indications

No indication recorded.